Repository logo
 

KIR haplotypes are associated with late-onset type 1 diabetes in European-American families.

Published version
Peer-reviewed

Repository DOI


Type

Article

Change log

Authors

Traherne, JA 
Valdes, AM 
Hollenbach, JA 
Jayaraman, J 

Abstract

Classical human leukocyte antigens (HLA) genes confer the strongest, but not the only, genetic susceptibility to type 1 diabetes. Killer cell immunoglobulin-like receptors (KIR), on natural killer (NK) cells, bind ligands including class I HLA. We examined presence or absence, with copy number, of KIR loci in 1698 individuals, from 339 multiplex type 1 diabetes families, from the Human Biological Data Interchange, previously genotyped for HLA. Combining family data with KIR copy number information allowed assignment of haplotypes using identity by descent. This is the first disease study to use KIR copy number typing and unambiguously define haplotypes by gene transmission. KIR A1 haplotypes were positively associated with T1D in the subset of patients without the high T1D risk HLA genotype, DR3/DR4 (odds ratio=1.29, P=0.0096). The data point to a role for KIR in type 1 diabetes risk in late-onset patients. In the top quartile (age of onset>14), KIR A2 haplotype was overtransmitted (63.4%, odds ratio=1.73, P=0.024) and KIR B haplotypes were undertransmitted (41.1%, odds ratio=0.70, P=0.0052) to patients. The data suggest that inhibitory 'A' haplotypes are predisposing and stimulatory 'B' haplotypes confer protection in both DR3/DR4-negative and late-onset patient groups.

Description

Keywords

Age of Onset, Child, Diabetes Mellitus, Type 1, Female, Genetic Association Studies, Genetic Predisposition to Disease, HLA Antigens, Haplotypes, Humans, Male, Receptors, KIR, White People

Journal Title

Genes Immun

Conference Name

Journal ISSN

1466-4879
1476-5470

Volume Title

17

Publisher

Springer Science and Business Media LLC
Sponsorship
Medical Research Council (G0901682)
Wellcome Trust (100140/Z/12/Z)
This work was supported in part by National Institutes of Health award R01 DK61722 (J.A.N.). Research in the Trowsdale lab is supported by the MRC and Wellcome Trust with part funding from the National Institute for Health Research Cambridge Biomedical Research Centre.